Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?

M Olmedo; E Reigadas; M Valerio; S Vázquez-Cuesta; J A Pajares; A Matilla; P Muñoz; E Bouza

Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?

Rev Esp Quimioter. 2019 Apr;32(2):205-207. Epub 2019 Mar 8.

Authors

M Olmedo¹, E Reigadas, M Valerio, S Vázquez-Cuesta, J A Pajares, A Matilla, P Muñoz, E Bouza²

Affiliations

¹ María Olmedo Samperio. Servicio de Microbiología Clínica y Enfermedades Infecciosas. Hospital General Universitario Gregorio Marañón. Madrid, Spain. maria.olmedo.samperio@gmail.com.
² Emilio Bouza Santiago, Instituto de Investigación Sanitaria Gregorio Marañón. Madrid, Spain. emilio.bouza@gmail.com.

PMID: 30847461
PMCID: PMC6441988

No abstract available

©The Author 2019. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).

Publication types

Case Reports
Letter

MeSH terms

Aged
Aged, 80 and over
Clostridioides difficile*
Enterocolitis, Pseudomembranous / complications*
Enterocolitis, Pseudomembranous / microbiology
Enterocolitis, Pseudomembranous / therapy*
Fecal Microbiota Transplantation*
Female
Humans
Liver Cirrhosis / complications*
Male
Middle Aged
Recurrence
Treatment Outcome